Biocompatibles is pleased to announce the acquisition of the business and net assets of BrachySciences Inc. and its affiliated companiesi (together “BrachySciences”) for a total consideration of up to US$21.6 million (c.£10.9 million), of which up to US$8.6 million (c.£4.4 million) is payable at closing and a further US$12 million is payable based on the achievement of EBIT-
related milestones over the years 2009-2011 ii.
